Drugs / MMV688533
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT05205941 | Mar → Sep 2022 | malaria | Medicines for Malaria Venture | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT04323306 Comparator | Aug 2020 → Sep 2022 | malaria | Medicines for Malaria Venture | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MMV688533 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05205941 ↗ |
| Route | Oral | “single oral doses of MMV533” NCT05205941 ↗ |